Peak Therapeutics Limited
09409822
Some Concerns
- No accounts filed in last 18 months (-5)
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/01/2025
unaudited abridged
Next accounts due
31/10/2026
Confirmation statement
Last: 14/02/2026
Due 28/02/2027
Industry
Officers
secretary · Since 01/04/2015
Persons with Significant Control
Dr Mark Peakman
British · England · Age 67
12, Beckwith Road, London, SE24 9LG
Notified 06/04/2016
CompanyRankvs 2879+ SIC 86220 peers75
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/01/2025
Net Worth
£392k
Balance sheet strength
Cash
£388k
Cash in the bank
Net Current Assets
£392k
Working capital
Current Assets
£398k
Current Liabilities
£6k
Fixed Assets
£437
Debtors
£10k
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 63.57 | +£18k |
| 2024 | 31.52 | +£45k |
| 2023 | 14.94 | — |
Derived from filed accounts. Not audited figures.